Prof. MD. Duygu Derin
Prof. MD. Duygu Derin
Prof. MD.

Duygu Derin

Liv Hospital Ulus
Medical Oncology
Areas of Interests
    • Breast Cancer
    • Colon Cancer
    • Lung Cancer
    • Ovary Cancer
International Articles
Education and Experiences
  • 2016 – Currently: Liv Hospital Ulus Hospital
  • Medical Oncologist in Neolife Oncology Center
  • Assoc. Prof. of Medical Oncology in 2010 
  • Medical Oncologist in İstanbul American Hospital in 2009-2010   
  • Compulsory Service in Kayseri Training and Research Hospital between 2006-2008 
  • Medical Oncology specialisation in İstanbul University İstanbul Medical Faculty  Onkology Institute in 2003-2006 
  • Internal Diseases specialisation in Taksim Training and Research Hospital in 2001 
  • Graduation from İstanbul University İstanbul Medical Faculty in 1993 
  • Graduation from Galatasaray Lycee in 1987
  • A phase 3 study of the new Epatilon BMS247550+capesitabine in patients with advanced breast cancer previously treated with an anthracycline or taxane. Prot no: CA163048. Coordination center: Hacettepe Medical Faculty. Responsible coordinator: Prof. Dr. Esmen Baltaci. Co-investigator: Dr. Duygu Derin
  • A phase 3 randomized placebo-controlled double-blind study comparing oral CCI-779 in combination with letrozole versus letrozole alone in first-line hormone therapy in postmenopausal women with locally advanced or metastatic breast carcinoma. Prot no: 3066A1-303WW. Coordination center: Istanbul University Oncology Institute. Responsible coordinator: Prof.Dr. Pınar Saip. Co-investigator: Dr. Duygu Derin
  • Soydinc, H.O., Duranyildiz, D., Guney, N., Derin, D., Yasasever, V. ''Utility of serum and urine uPAR levels for diagnosis of breast cancer. Asian Pac J Cancer Prev. 2012;13(6):2887-9.
  • Vural, B., Yakar, F., Derin, D., Saip, P., Yakar, A., Demirkan, A., Karabulut, A., Ugurel, E., Cine, N., Kilicaslan, Z., Tüzün, E., Ozbek, U. ''Küçük hücreli akciğer kanserli hastalarda glutatyon S-transferaz P1 polimorfizmlerinin (Ile105Val ve Ala114Val) değerlendirilmesi. Genet Test Mol Biomarkers. 2012 Jul;16(7):701-6. doi: 10.1089/gtmb.2011.0315. Epub 2012 Feb 17.
  • Saip, R., Sen, F., Vural, B., Ugurel, E., Demirkan, A., Derin, D., Eralp, Y., Camlica, H., Ustuner, Z., Ozbek, U. ''Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients. J BUON. 2011 Apr-Jun;16(2):241-6.
  • Ozluk, Y., Kilicaslan, I., Kazancioglu, R., Demirkesen, C., Derin, D., Mandel, N.M. ''Intraglomerular crescentic metastases of malignant melanoma. Hum Pathol. 2011 Dec;42(12):2025-8. doi: 10.1016/j.humpath.2010.05.032. Epub 2011 Jun 12.
  • Beyazıt, H., Aydın, O., Demirkesen, C., Derin, D., Süt, P., Emre, A., Mandel,N. ''Gastrik adenokarsinom seyri sırasında pankreas tutulumunun ilk belirtisi olarak pankreatik pannikülit'' Med Oncol. 2011 Mar;28(1):137-9. doi: 10.1007/s12032-010-9420-8. Epub 2010 Jan 30.
  • Bitisik, O., Saip, P., Saglam, S., Derin, D., Dalay, N. ''Mammaglobin and maspin transcripts in blood may reflect disease progression and treatment effect in breast cancer. Genet Mol Res. 2010;9(1):97-106.
  • Basaran, G., Okkan, S., Çaglar, H., Benekli, M., Gümüş, M., Haydaroğlu , A., Eralp, Y., Abalı, H., Yıldız, F., Bese, N., Gursel, B., Guney, N., Derin, D. ''Immunohistochemically Defined T1N0 Breast Cancer SungroupsHave Different Clinical Outcomes. A Retrospective Turkish Oncology Group Study. '' Cancer Research 02/2010 69(24 supplement) 3167-3167 DOI: 10.11580008-5472 SABCS-09-3167
  • Can, G., Topuz, E., Derin, D., Durna, Z., Aydıner, A. ''The effect of kefir on quality of life in colorectal cancer patients. Oncol Nurs Forum. 2009 Nov;36(6):E335-42. doi: 10.1188/09.ONF.E335-E342.
  • Guney, N., Soydinc, H.O., Basaran, M., Bavbek, S, Derin, D., Camlica, H., Yasasever, V., Topuz, E. ''Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma. Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):669-74.
  • Guney, N., Sayilgan, T., Derin, D., Ozcan, D. ''Primary carcinoid tumor arising in mature cystic teratoma of the ovary: a case report''. Eur J Gynaecol Oncol. 2009;30(2):223-5.
  • Medical Oncology Society 
  • Chamber of Medicine
  • Galatasaraylılar Fan Society
  • Turkish Cancer Research and Warfare Organization (XVIIth National Cancer Congress) Oncology Research Second Prize: Oguzsoydinç,H., Çamlıca, H., Duranyılmaz, D., Güney, N., Derin, D., Taş, F., Dalay, N., Yasasever, V. "The Utility of the Serum and Urine UPAR Levels in Breast Cancer''
Ask our Experts!
You can contact with our experts for your questions!

Liv Health Guide

Left Arrow
Right Arrow
Recommendations for Fatigue During Cancer Treatment
Recommendations for Fatigue During Cancer Treatment

Fatigue can be seen as a result of anemia, endocrine changes, and respiratory distress that are induced by cancer, and can also be seen in advanced cancer patients.

cancer treatment
sleep and rest
Robotic Lung Cancer Treatment In 5 Questions
Robotic Lung Cancer Treatment In 5 Questions

Lung cancer, the most common cause cancer-related deaths, can be treated successfully in early stages. 

robotic surgery
early stages
Medical Oncology in Turkey
Medical Oncology in Turkey

You can find in our article the things you are interested in about medical oncology, such as diseases that are areas of interest of medical oncology, and treatment methods used in medical oncology.

hematological cancers
breast cancer
brain cancer
What is Bone Cancer?
What is Bone Cancer?

Bone cancer is a rare form of cancer that originates in the bones.

bone pain
Medical Oncology
Medical Oncology

Cancer is a globally prevalent health problem that poses a threat to public health worldwide.